Projects

RNDr. Monika Sláviková, PhD.

International

Finished
  • Aedes Invasive Mosquitoes
    Program: COST
    Duration: 29. 1. 2020 – 5. 3. 2023
  • European virus archive goes global.
    Program: Horizon 2020
    Duration: 1. 4. 2015 – 31. 3. 2019
  • Anti-tick Vaccines to Prevent Tick-borne Diseases in Europe
    Program: FP7
    Duration: 1. 12. 2013 – 30. 11. 2018
  • Development of galectin-based therapeutics for the treatment of hantaviral hemorrhagic fever
    Program: ERANET
    Duration: 1. 1. 2016 – 31. 12. 2017

National

Current
  • Development of albumin and dendrimer-based nanosystems against tick-borne encephalitis virus
    Program: SRDA
    Duration: 1. 9. 2024 – 30. 6. 2028
  • Warranty of blood safety towards mosquito-borne viruses infections in the era of global change
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
Finished
  • Ecology of West Nile virus in globally changing environment
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • Functional analysis and production of bioactive subsatnces in insects and ticks
    Program: SRDA
    Duration: 1. 7. 2019 – 30. 6. 2023
  • Improvement of the biotechnological research potential of the Biomedical Research Center of the Slovak Academy of Sciences to combat the pandemic COVID-19 in synergy with the European Virus Archive of Global Importance supported by the H2020 program
    Program:
    Duration: 1. 4. 2020 – 30. 6. 2023
  • Virulence factors of tick-borne encephalitis virus and their role in transmission via tick vector
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2022
  • Of Sheep, Goats and Tick-borne Encephalitis virus
    Program: SRDA
    Duration: 1. 7. 2017 – 31. 12. 2021
  • Immune response to SARS-CoV-2 infection and development of clinically relevant virological tests to improve the management of the COVID-19 pandemic
    Program: SRDA
    Duration: 16. 9. 2020 – 31. 12. 2021
  • The virus, the tick, and blood: gene expression analysis of the tick Ixodes ricinus in the context of tick-borne encephalitis virus infection and feeding
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2019
  • Usage of next-generation sequencing for virome analysis of medically and economically relevant organisms.
    Program: SRDA
    Duration: 1. 7. 2016 – 30. 6. 2019
  • Hantaviruses and crossing of the species barriers
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2017
  • Biological significance and pharmacological features of bioactive proteins in tick saliva
    Program: SRDA
    Duration: 1. 10. 2013 – 30. 9. 2017
  • Bioactive molecules in tick saliva and their exploitation in the regulation of cell processes in physiological and physiological conditions
    Program: VEGA
    Duration: 1. 1. 2013 – 31. 12. 2016
  • Molecular determinants of non-viraemic transmission of tick-borne encephalitis between co-feeding ticks
    Program: VEGA
    Duration: 1. 1. 2012 – 21. 12. 2014
  • Identification of selected bioactive molecules secreted in tick saliva
    Program: VEGA
    Duration: 1. 1. 2010 – 31. 12. 2012
  • Structural and functional analysis of new candidates of anti-tick vaccines
    Program: VEGA
    Duration: 1. 1. 2010 – 31. 12. 2012
  • Identification, expression and use of bioactive substances from parasitic helmints, ticks and insects in clinical medicine
    Program:
    Duration: 1. 1. 2009 – 30. 10. 2010
  • Molecular-biological characterization of selected tick’s salivary proteins as a potential antigens for development of anti-tick vaccines
    Program: VEGA
    Duration: 1. 1. 2007 – 31. 12. 2009
  • Effects of tick saliva immunosupressant on host immune system and pathogen transmission
    Program: VEGA
    Duration: 1. 1. 2007 – 31. 12. 2009
Employees